CXCL12 and breast cancer: This study showed that E5 was capable of inhibiting the interaction between 4T1 breast cancer cells and stromal cells mediated by CXCL12, leading to a reduction in migration and adhesion and enhancing the sensitivity of these cells to chemotherapeutics both in vitro and in vivo.